Development of a Semi-Mechanistic IVT Bioreactor Model for Scalable and Flexible Therapeutic mRNA Production Platforms
Capuano, Marcella
Russo, Maria Elena
Sasso, Emanuele
Froechlich, Guendalina
Nicosia, Alfredo
Maffettone, Pier Luca
Marzocchella, Antonio
Salatino, Piero
Pdf

How to Cite

Capuano M., Russo M.E., Sasso E., Froechlich G., Nicosia A., Maffettone P.L., Marzocchella A., Salatino P., 2026, Development of a Semi-Mechanistic IVT Bioreactor Model for Scalable and Flexible Therapeutic mRNA Production Platforms, Chemical Engineering Transactions, 128, 79-84.
Pdf

Abstract

The production of genetic vaccines increased rapidly during the SARS-CoV-2 pandemic and is now being explored for several therapies, including cancer immunotherapy. mRNA vaccines are produced through in vitro transcription (IVT), purification, and formulation into lipid nanoparticles. Different therapeutic targets require different production scales (from kilograms for influenza vaccines to milligrams for personalized therapies), which require careful process optimization and decentralized manufacturing to enhance local accessibility. Recent contributions in the field of biochemical reaction engineering proposed kinetic models and design strategies for semi-continuous and continuous IVT reactors, based on earlier research focused on batch and fed-batch systems. This study is part of a multidisciplinary project aimed at developing a bench-scale platform for (semi)continuous mRNA production. The main target is anti-cancer therapy using mRNA encoding antigens and immune-modulating adjuvants. An equilibrium model (EqIVTM) was developed to describe the speciation of electrolytes in the IVT media and extended to a well-mixed batch IVT model (BIVTRM) including differential mass balances for key species involved in the enzymatic transcription. Simulations performed with COMSOL Multiphysics enabled the prediction of the dynamics of electrolyte and mRNA concentrations under conditions set according to relevant protocols for therapeutic mRNA and adjuvant screening.
Pdf